These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9155851)

  • 61. Which is the optimal bronchodilator therapy for chronic obstructive pulmonary disease?
    Baloira A
    Expert Rev Respir Med; 2013 Apr; 7(2 Suppl):17-24. PubMed ID: 23551020
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Optimizing maintenance therapy for chronic obstructive pulmonary disease: strategies for improving patient-centered outcomes.
    Hanania NA
    Clin Ther; 2007 Oct; 29(10):2121-33. PubMed ID: 18042470
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clinical inquiries. Are beta-2-agonists or anticholinergics more effective for treating COPD?
    Richmond JR; Babcock CF; Mayo H; Hoekzema G
    J Fam Pract; 2004 Jun; 53(6):494-6. PubMed ID: 15189726
    [No Abstract]   [Full Text] [Related]  

  • 64. Formoterol (Perforomist) for COPD.
    Med Lett Drugs Ther; 2007 Nov; 49(1274):94-5. PubMed ID: 18007544
    [No Abstract]   [Full Text] [Related]  

  • 65. The role of anticholinergics in 'stable' chronic obstructive pulmonary disease: unanswered questions.
    Wiggins J
    Respiration; 1994; 61(6):303-4. PubMed ID: 7824808
    [No Abstract]   [Full Text] [Related]  

  • 66. Asthma therapy with aerosols: clinical relevance for the next decade.
    Barnes PJ
    J Aerosol Med; 1996; 9(1):131-41. PubMed ID: 10160203
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Anticholinergic drugs in the therapy of obstructive airway diseases].
    Windt R
    Med Monatsschr Pharm; 2011 Apr; 34(4):130-7. PubMed ID: 21528530
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Chronic obstructive pulmonary disease.
    Kerstjens H; Postma D
    Clin Evid; 2002 Jun; (7):1344-57. PubMed ID: 12243121
    [No Abstract]   [Full Text] [Related]  

  • 69. [Acute exacerbations of chronic obstructive pulmonary disease: special reference to pathophysiology and management].
    Yamada K; Kida K
    Nihon Rinsho; 1999 Sep; 57(9):2062-8. PubMed ID: 10497407
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Inhaler devices for patients with COPD.
    Fink JB; Colice GL; Hodder R
    COPD; 2013 Aug; 10(4):523-35. PubMed ID: 23537191
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Austrian Society for Lung Diseases and Tuberculosis: Consensus on diagnosis and therapy of bronchial asthma in adults. Revised draft 1999].
    Aigner K; Block LH; Kneussl M; Kummer F; Neumann M; Zach M; Zwick H
    Wien Klin Wochenschr; 1999 Dec; 111(24):1044-7. PubMed ID: 10677892
    [No Abstract]   [Full Text] [Related]  

  • 72. [Morbidity and mortality from obstructive lung disease among Norwegian children].
    Carlsen KH; Lødrup KC; Carlson O; Mowinckel P
    Tidsskr Nor Laegeforen; 1990 Jun; 110(16):2068-71. PubMed ID: 1973310
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Chronic obstructive pulmonary disease in combination with cardiovascular diseases: treatment with inhalatory cholinolytic drugs].
    Aĭsanov ZR; Kalamanova EN; Chuchalin AG
    Ter Arkh; 2004; 76(12):81-2. PubMed ID: 15724935
    [No Abstract]   [Full Text] [Related]  

  • 74. The use of bronchodilators in stable chronic obstructive pulmonary disease.
    Cazzola M; Spina D; Matera MG
    Pulm Pharmacol Ther; 1997 Jun; 10(3):129-44. PubMed ID: 9514624
    [No Abstract]   [Full Text] [Related]  

  • 75. [Treatment of acute and chronic airway obstruction with bronchospasmolytics in general practice].
    Geisler LS
    Dtsch Med Wochenschr; 1980 Aug; 105(34):1189-91. PubMed ID: 6109619
    [No Abstract]   [Full Text] [Related]  

  • 76. Use of a long-acting inhaled beta2-adrenergic agonist, salmeterol xinafoate, in patients with chronic obstructive pulmonary disease.
    Rennard SI; Anderson W; ZuWallack R; Broughton J; Bailey W; Friedman M; Wisniewski M; Rickard K
    Am J Respir Crit Care Med; 2001 Apr; 163(5):1087-92. PubMed ID: 11316640
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Considerations in office management of chronic obstructive pulmonary disease.
    Schwartz AM
    J Am Osteopath Assoc; 1981 Aug; 80(12 Suppl):866-9. PubMed ID: 6115835
    [No Abstract]   [Full Text] [Related]  

  • 78. [Fixed-dose combination of proven active ingredients in new inhaler].
    Koczorek M
    Med Monatsschr Pharm; 2014 Sep; 37(9):341-2. PubMed ID: 25282752
    [No Abstract]   [Full Text] [Related]  

  • 79. Chronic obstructive pulmonary disease: the evidence for use of tiotropium.
    Burns G; Bianchi S
    Br J Hosp Med (Lond); 2006 Feb; 67(2):85-91. PubMed ID: 16498916
    [No Abstract]   [Full Text] [Related]  

  • 80. Long acting beta(2) agonists and theophylline in stable chronic obstructive pulmonary disease.
    Cazzola M; Donner CF; Matera MG
    Thorax; 1999 Aug; 54(8):730-6. PubMed ID: 10413727
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.